Craneware (GB:CRW) has released an update.
Craneware, a market leader in value cycle solutions for the U.S. healthcare sector, has announced that certain directors and shareholders have agreed to sell a total of 850,000 ordinary shares at £22.00 each. This sale represents about 2.4% of the company’s existing issued share capital, excluding treasury-held shares. Notably, the CEO and a co-founder have agreed to a 365-day lock-up period on further sales, with the transaction expected to settle around September 16, 2024.
For further insights into GB:CRW stock, check out TipRanks’ Stock Analysis page.
